EUVIMEDEUVIMED entdecken
Crossref

METTL3 facilitates the malignant progression of prostate cancer by inhibiting GDF15-mediated ferroptosis via a YTHDF1-dependent m6A mechanism

Jun Jiang, Jinming Li, Shaoxing Wang, Jiahao Liu, Shusen Zuo

Pathology - Research and Practice · 2026

DOI: 10.1016/j.prp.2026.156395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Jun Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xingtai Cancer Hospital, Xingtai, Hebei, China. Electronic address: junjiang198410@163.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Methyltransferases, Growth Differentiation Factor 15, Ferroptosis. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prostate cancer (PCa) represents one of the most common tumors in males. Growth differentiation factor 15 (GDF15), a divergent member of the transforming growth factor β (TGF-β) family, exhibits elevated expression that correlates with cancer progression (including PCa). The RNA N6-methyladenosine (m6A) modification, an epigenetic regulatory mechanism, has been implicated in oncogenesis and tumor advancement. Therefore, this study aims to delineate the functional role of GDF15 in PCa progression. METHODS: Differentially expressed genes (DEGs) and GDF15 levels in tumor tissues were analyzed using Gene Expression Omnibus (GEO) and Tumor Immune Estimation Resource (TIMER) database. Gene levels were detected by reverse transcription-quantitative polymerase chain reaction (qRT-PCR) and western blot. Cell proliferation, migration, and sphere-forming abilities were examined using colony formation, transwell, and spheroid formation assays. Reactive-oxygen species (ROS), superoxide dismutase (SOD), malondialdehyde (MDA), and ferrous iron (Fe2 +) levels were examined using corresponding detection kits. Methylation sites of GDF15 were predicted by SRAMP database. Relationship between GDF15 and methyltransferase-like 3/YTH domain family member 1 (METTL3/YTHDF1) was detected using RNA immunoprecipitation (RIP). mRNA stability was analyzed using qRT-PCR. Effects of METTL3 and GDF15 in vivo were confirmed via animal experiment. RESULTS: GDF15 expression was highly expressed in PCa tissues and cells. Functionally, GDF15 knockdown repressed PCa cell proliferation, migration, and sphere-forming abilities and promoted ferroptosis. Mechanistically, METTL3 combined with YTHDF1 regulated the m6A methylation of GDF15. METTL3 silencing suppressed the malignant biological behaviors of PCa cells via regulating GDF15. In vivo, silencing METTL3 inhibited tumor growth and GDF15 expression. CONCLUSION: Silencing METTL3 inhibits the malignant biological progression of PCa by mediating GDF15 via a YTHDF1-dependent m6A mechanism. It is important to further research GDF15 and reveal its specific mechanism in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMethyltransferasesGrowth Differentiation Factor 15FerroptosisRNA-Binding ProteinsMaleHumansDisease ProgressionAnimalsGene Expression Regulation, NeoplasticRNA MethylationAdenosineCell ProliferationEpitranscriptome

Stichwörter der Autor:innen

FerroptosisGrowth differentiation factor 15Malignant progressionMethyltransferase-like 3Prostate cancer

Substanzen

MethyltransferasesGrowth Differentiation Factor 15METTL3 protein, humanRNA-Binding ProteinsGDF15 protein, humanYTHDF1 protein, humanAdenosineN-methyladenosine

Autor:innen und Institutionen

  • Department of Urology, Xingtai Cancer Hospital, Xingtai, Hebei, China. Electronic address: junjiang198410@163.com.
  • Department of Urology, Xingtai Cancer Hospital, Xingtai, Hebei, China.

Zitieren

APA

Jiang, J., Li, J., Wang, S., Liu, J., & Zuo, S. (2026). METTL3 facilitates the malignant progression of prostate cancer by inhibiting GDF15-mediated ferroptosis via a YTHDF1-dependent m6A mechanism. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2026.156395

Vancouver

Jiang J, Li J, Wang S, Liu J, Zuo S. METTL3 facilitates the malignant progression of prostate cancer by inhibiting GDF15-mediated ferroptosis via a YTHDF1-dependent m6A mechanism. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2026.156395

BibTeX
@article{Jiang2026,
  author = {Jiang, Jun and Li, Jinming and Wang, Shaoxing and Liu, Jiahao and Zuo, Shusen},
  title = {METTL3 facilitates the malignant progression of prostate cancer by inhibiting GDF15-mediated ferroptosis via a YTHDF1-dependent m6A mechanism},
  journal = {Pathology - Research and Practice},
  year = {2026},
  doi = {10.1016/j.prp.2026.156395}
}
Kostenlos starten →